Both in Pharmaceuticals
Protagonist Therapeutics vs Corcept Therapeutics
Over the past year PTGX returned +87.4% and CORT returned +11.4%; their daily moves had a correlation of 0.22.
PTGX +87.4% CORT +11.4%Growth of $1, one year, split-adjusted
| Metric | PTGX | CORT |
|---|---|---|
| Price | $143.37 | $79.22 |
| Market cap | $9.28B | $8.56B |
| Today | +2.23% | −3.31% |
| 1 month | +3.4% | −33.7% |
| 6 months | +37.9% | +51.9% |
| Year to date | +64.2% | +127.6% |
| 1 year | +88.8% | +6.8% |
| Revenue growth (YoY) | +3749.2% | +31.7% |
| Gross margin | 100.0% | 98.4% |
| Net margin | 76.3% | 16.8% |
| P/E (TTM) | 111.9× | 157.2× |
| Price / sales | 32.9× | 10.3× |
| Net cash | $782.6M | $308.2M |
| Dividend yield | — | — |
| Volatility (60d) | 32.0% | 59.5% |
| Short % of float | 16.8% | 9.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).